#antitubercular

[ijcimr]

Calvarial Tuberculosis BY  Eleni Ischaki IN International Journal of Clinical Images and Medical Reviews  

A 19-year-old boy presented with status epilepticus. Computed tomography of the brain showed a big, multilobular mass, with peripheral oedema in the frontal lobe which was enhanced peripherally after intravenous administration of a contrast agent. The mass penetrated the frontal bone and extended subcutaneously. He immediately underwent right decompression craniectomy. An empyema was found and was drained. Microscopic examination of brain, dura mater and bone tissue specimens revealed a necrotizing granulomatous inflammation. Tissue cultures were positive for Mycobacterium tuberculosis. The patient received a 4-regimen antitubercular treatment combined with dexamethasone due to central nervous system penetration of the disease with complete response in the follow-up.

For more details: https://ijcimr.org/editorial-board/ 

[luckyspharma]

Pharma Companies in Uttarakhand

Pharma Companies in Uttarakhand - Uttarakhand is home to some of the most renowned pharmaceutical companies in India. The state has some of the best-equipped laboratories and production facilities, making it an ideal destination for the pharmaceutical industry. With the presence of many pharmaceutical giants in the state, Uttarakhand is becoming a preferred destination for the pharmaceutical industry. In this article, we will be taking a look at the top Pharma Companies in Uttarakhand.

Top Pharma Companies in Uttarakhand 2024

The pharmaceutical industry is growing rapidly in the state and the region has become a hub of drug production and distribution. Here is the list of the top 10 pharma companies in Uttarakhand -

Luckys Pharma | Best Pharma Company in Uttarakhand 

Luckys Pharma is one of the leading pharmaceutical companies in Uttarakhand. The company manufactures and markets a wide range of pharmaceutical products and services. Luckys Pharma has been at the forefront of introducing new and advanced medicines for various diseases. It has also established several research and development facilities in the state. Also, they are ISO: 9001:2015 certified, with a product that reflects their commitment to quality and excellence.

Contact Details:

Name –  Lucky Pharma 

Address – Plot No. 82, 1st Floor, Jaora Compound, Near Police Lines, Indore (MP)

Mail –  info@luckyspharma.com

Phone –  08889909733, 08889909734

Aurobindo Pharma

Aurobindo Pharma is one of the leading pharmaceutical companies in India. The company is headquartered in Uttarakhand and has several production and research facilities in the state. The company manufactures and markets a wide range of pharmaceutical products such as antibiotics, antifungal agents, anti-malarial drugs, antitubercular drugs, etc.

Emcure Pharmaceuticals

Emcure Pharmaceuticals Ltd. is another leading pharmaceutical company in India. Emcure has a strong presence in Uttarakhand, with its plant located at Haridwar. Emcure has a wide range of products, which include generic drugs, branded drugs, OTC drugs, and specialty drugs. Its products are used to treat various diseases, such as diabetes, cancer, heart diseases, and respiratory diseases.

Sun Pharmaceuticals

Sun Pharmaceuticals is another leading pharmaceutical company in India. The company manufactures and markets a wide range of pharmaceutical products which include antibiotics, antifungal agents, anti-malarial drugs, antitubercular drugs, etc. The company also has a strong research and development facility in the state.

Ranbaxy Laboratories

Ranbaxy Laboratories is one of the largest and most reputed pharmaceutical companies in India. The company is headquartered in Uttarakhand and has several production and research facilities in the state. The company manufactures and markets a wide range of pharmaceutical products such as antibiotics, antifungal agents, anti-malarial drugs, antitubercular drugs, etc.

Ravic Healthcare

Ravic Healthcare is one of the leading pharmaceutical companies in India and is headquartered in Uttarakhand. The company manufactures and markets a wide range of pharmaceutical products including antibiotics, antifungal agents, anti-malarial drugs, antitubercular drugs, etc. The company also has a strong research and development facility in the state.

Torrent Pharmaceuticals

Torrent Pharmaceuticals Ltd. is another leading pharmaceutical company in India, with its headquarters in Ahmedabad. Torrent has a strong presence in Uttarakhand, with its plant located at Haridwar. Torrent has a wide range of products, which include generic drugs, branded drugs, OTC drugs, and specialty drugs. Its products are used to treat various diseases, such as diabetes, and cancer.

Sonika Life Science

Sonika Life Science is another leading pharmaceutical company in Uttarakhand. The company manufactures and markets a wide range of pharmaceutical products including antibiotics, antifungal agents, anti-malarial drugs, antitubercular drugs, etc. The company also has a strong research and development facility in the state.

Conclusion

Uttarakhand is a preferred location for the pharmaceutical industry and is home to some of the leading pharmaceutical companies in India. The presence of several pharmaceutical giants in the state has enabled the industry to flourish and provide quality products and services to the people of the region. Top Pharma companies of Uttarakhand have played an important role in the growth of the industry in the state.

[nuadox]

Nanoparticles with antibacterial action shorten duration of tuberculosis treatment

- By Julia Moióli , Agência FAPESP -

A low-cost technology involving nanoparticles loaded with antibiotics and other antimicrobial compounds that can be used in multiple attacks on infections by the bacterium responsible for most cases of tuberculosis has been developed by researchers at São Paulo State University (UNESP) in Brazil and is reported in an article published in the journal Carbohydrate Polymers.

Results of in vitro tests suggest it could be the basis for a treatment strategy to combat multidrug bacterial resistance.

According to Brazil’s Health Ministry, some 78,000 cases of tuberculosis were notified in 2022, 5% more than in the previous year and more than in any other country in the Americas. In addition to the rise in incidence, the number of cases involving multidrug-resistant strains is also growing. 

The main agent of the disease is the bacillus Mycobacterium tuberculosis, one of the most lethal bacteria known to scientists. Transmission occurs via inhalation of bacilli, which migrate to the pulmonary alveoli, causing inflammation of the airways and eventually destroying lung tissue. 

The use of nanotechnology is one of the novel treatment strategies considered most promising by scientists around the world against multidrug-resistant strains of M. tuberculosis. The UNESP study, which was funded by FAPESP (projects 20/16573-3, 22/09728-6 and 23/01664-1), analyzed the antitubercular activity of nanoparticles comprising N-acetylcysteine (an over-the-counter supplement), chitosan (a natural compound derived from the outer skeleton of shellfish), an antimicrobial peptide originally isolated from the skin of a Brazilian frog species, and rifampicin (an antibiotic commonly used to treat tuberculosis).

The results showed that the nanoparticles significantly inhibited progression of the disease and overcame resistance to the drug without causing cell damage.

In vitro assays were performed with M. tuberculosis-infected fibroblasts, the main cells active in connective tissue, and macrophages, cells of the innate immune system and a key component of first-line defense against pathogens.

“Rifampicin is considered obsolete for certain strains of the bacillus, but in our study, we revitalized and optimized it with antimicrobial peptides that have been proven to help combat the disease,” said Laura Maria Duran Gleriani Primo, first author of the article and an undergraduate student at UNESP’s School of Pharmaceutical Sciences with a scientific initiation grant. 

“These peptides interact with various receptors in different parts of the bacterium, in both the membrane and periplasm. We found that they revitalized rifampicin, which became even more active inside macrophages,” said Cesar Augusto Roque-Borda, joint first author of the study and a PhD candidate in UNESP’s Program of Graduate Studies in Biosciences and Pharmaceutical Biotechnology. The periplasm is a region of bacterial cells that lies between the inner cytoplasmic and outer bacterial membranes of the cell envelope.

Prospects

Conventional treatment of tuberculosis entails concomitant use of several antiobiotics for six months to about two years depending on the patient’s response and the bacterium’s resistance. The researchers expect their technique to shorten this time.

“From the study, we know it’s possible to insert a considerable concentration of antibiotic and peptides into macrophages – enough to boost the effect of the treatment,” said Fernando Rogério Pavan, last author of the article and a professor at UNESP’s School of Pharmaceutical Sciences. “Our expectations for future research include using this type of nanotechnology with other drugs and slow-release medications so that patients don’t need to take their medication every day.”

The next step will be to confirm the in vitro findings by means of in vivo trials and study the use of the nanoparticles to combat other diseases that require treatment for long periods.

The article “Antimicrobial peptides grafted onto the surface of N-acetylcysteine-chitosan nanoparticles can revitalize drugs against clinical isolates of Mycobacterium tuberculosis” is at: www.sciencedirect.com/science/article/abs/pii/S0144861723009141?via%3Dihub. 

Image: Graphical abstract of the study (image created by Cesar Augusto Roque-Borda using free version of biorender.com)

This text was originally published by FAPESP Agency according to Creative Commons license CC-BY-NC-ND. Read the original here.

--

Read Also

A practical and effective novel community-based TB diagnostic technology

[ameerunsblog]

Antitubercular Drugs Question And Answers

[divyaspuramworld]

Antitubercular Drugs Question And Answers

[rohans18]

Leprostatics Drugs Market Share, Size, Research, CAGR, and Growth - Forecast 2028

Global Leprostatics Drugs Market, By Drug Type (Antibacterial, Leprostatics, Antitubercular, Antileprosy and Others), Treatment Type (Medication, Supportive Care, Multi Drug Therapy (MDT)), Route of Administration (Oral, Parenteral, Intravenous, Topical), Mode of Purchase (Prescription and Over the Counter), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Others), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028

In the consistent Leprostatics Drugs market research report, industry trends are put together on macro level with which clients can figure out market landscape and possible future issues about Leprostatics Drugs industry. The scope of this market report include but is not limited to latest trends, market segmentation, new market entry, industry forecasting, future directions, opportunity identification, strategic analysis and planning, target market analysis, insights and innovation. The report presents with the CAGR value fluctuations for the specific forecasted period which helps decide costing and investment strategies. An influential Leprostatics Drugs market report brings precise and exact market research information that drives business into the right direction.

Key Players

The major players covered in the Leprostatics Drugs market report are Helmer Scientific Inc, LABCOLD, Boekel Scientific, Sarstedt AG & Co. KG, Lmb Technologie GmbH, Terumo Corporation, Nuve Sanayi Malzemeleri Imalat ve Ticaret AS, Biobase, Biolab Scientific and Meditech Technologies India Private Limited, among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

 Browse More Info @ https://www.databridgemarketresearch.com/reports/global-leprostatics-drugs-market

The research studies entailed in the winning Leprostatics Drugs market report supports to estimate several important aspects that includes but are not limited to investment in a rising market, success of a new product, and expansion of market share. The strategies underlined here mainly consist of new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others that boost footprints in this market. Several other factors such as import, export, gross margin, price, cost, and consumption are also analyzed under the section of production, supply, sales and market status.

Key questions answered in the report:

Which product segment will grab a lion’s share?

Which regional market will emerge as a frontrunner in coming years?

Which application segment will grow at a robust rate?

Report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios of the top players in the Leprostatics Drugs Market.

Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market.

Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.

Table Of Content

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03:  Global Market

Part 04: Global Market Size

Part 05: Global Market Segmentation By Product

Part 06: Five Forces Analysis

 More Reports:

Diuretic Drugs Market

Patient Engagement Technology Market

Healthcare Business Intelligence Market

Chinese Hamster Ovary cells (CHO) Market

Anti-cancer Drug Market

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

[vasanthasworld]

Antitubercular Drugs Question And Answers

[lalitrajsingh]

Kanchnar_Karbudra I Bauhinia_variegata I

Holistic Health Conservation

Mountain_Ebony_Caesalpinaceae_DIY_Tonic_Goiter_Scrofula #Kanchnar #Karbudra #Bauhinia_variegata #Mountain_Ebony #Caesalpinaceae #DIY #Tonic #Goiter #Scrofula#ytviralvideos #astringent #Uterine_Fibroids #Earache #Vomitting #Herpes #Polio #DIY #kubadpan #herbalism #healthylifestyle #nature #Bones #arthritis #goite #expectorant #antitubercular #healthylifestyle #nutrients #poison #Piles #castor_oil…

[pearlsmith25]

Hydrazine Hhydrate Market Set to Witness Massive Growth Rate during Forecast 2022-2030

Hydrazine Hydrate is a colorless, fuming, oily liquid that has the chemical formula N2H4.H2O. It is also known as Hydrazinium Hydroxide. Hydrazine Hydrate is a powerful reducing agent and is commonly used in various industrial applications, such as in the production of pharmaceuticals, agricultural chemicals, and polymerization reactions. It is also used as a rocket propellant in the aerospace industry.

Hydrazine Hydrate is highly toxic and can be hazardous to handle. It is corrosive to many materials, including metals, plastics, and rubber, and it can cause severe burns on contact with the skin. Inhalation of the vapors can cause respiratory irritation, and ingestion can be fatal. Due to its hazardous nature, proper safety precautions and protective equipment are necessary when handling Hydrazine Hydrate. Additionally, it should only be used in a well-ventilated area and stored in a secure location away from other chemicals.

Major players operating in the global hydrazine hydrate market include Otsuka- MGC Chemical Company, Inc., Arkema SA, Lonza Group Ltd., Nippon Carbide Industries Co. Inc., Tanshang Chen Hong Industrial Co., Ltd., LANXESS, Japan FineChem Co., Inc., Hunan Zhuzhou Chemical Industry Group Co. Ltd., Yibin Tianyuan Group Co., Ltd., and Weifang Yaxing Chemical Co., Ltd.

The global Hydrazine Hydrate market is expected to grow at a moderate rate in the coming years. The market growth is mainly driven by the increasing demand for Hydrazine Hydrate in various end-use industries, such as pharmaceuticals, agricultural chemicals, and polymerization reactions.

The pharmaceutical industry is one of the major end-users of Hydrazine Hydrate. It is used as a key intermediate in the production of various drugs, such as antitubercular drugs, antidepressants, and antineoplastic agents. The increasing prevalence of diseases and the growing demand for effective drugs are expected to drive the demand for Hydrazine Hydrate in the pharmaceutical industry.

The agricultural chemicals industry is another major end-user of Hydrazine Hydrate. It is used as a herbicide and pesticide in crop protection applications. The growing demand for food due to the increasing population is expected to drive the demand for Hydrazine Hydrate in the agricultural chemicals industry.

The polymerization reactions industry is also expected to drive the demand for Hydrazine Hydrate. It is used as a chain extender in the production of various polymers, such as polyurethane and polyester. The increasing demand for polymers in various end-use industries, such as automotive and construction, is expected to drive the demand for Hydrazine Hydrate.

The demand for Hydrazine Hydrate is driven by its various industrial applications, particularly in the pharmaceuticals, agricultural chemicals, and polymerization reactions industries.

In the pharmaceutical industry, Hydrazine Hydrate is used as an intermediate in the synthesis of various drugs, such as antitubercular drugs, antidepressants, and antineoplastic agents. The increasing prevalence of diseases and the growing demand for effective drugs are expected to drive the demand for Hydrazine Hydrate in this industry.

In the agricultural chemicals industry, Hydrazine Hydrate is used as a herbicide and pesticide in crop protection applications. The increasing demand for food due to the growing population is expected to drive the demand for Hydrazine Hydrate in this industry.

In the polymerization reactions industry, Hydrazine Hydrate is used as a chain extender in the production of various polymers, such as polyurethane and polyester. The increasing demand for polymers in various end-use industries, such as automotive and construction, is expected to drive the demand for Hydrazine Hydrate.

Additionally, the increasing use of Hydrazine Hydrate as a rocket propellant in the aerospace industry is also expected to drive the demand for this chemical.

Hydrazine Hydrate is a versatile chemical compound that finds applications in various industries, including:

1. Pharmaceuticals: Hydrazine Hydrate is used as an intermediate in the synthesis of various drugs, such as antitubercular drugs, antidepressants, and antineoplastic agents.

2. Agricultural Chemicals: Hydrazine Hydrate is used as a herbicide and pesticide in crop protection applications.

3. Polymerization Reactions: Hydrazine Hydrate is used as a chain extender in the production of various polymers, such as polyurethane and polyester.

4. Rocket Propellant: Hydrazine Hydrate is used as a rocket propellant in the aerospace industry.

5. Water Treatment: Hydrazine Hydrate is used as an oxygen scavenger in water treatment applications.

6. Blowing Agents: Hydrazine Hydrate is used as a blowing agent in the production of foams and expanded plastics.

7. Photography: Hydrazine Hydrate is used as a developing agent in black and white photography.

8. Metal Surface Treatment: Hydrazine Hydrate is used as a reducing agent in the surface treatment of metals.

The global Hydrazine Hydrate market is expected to grow at a moderate rate in the coming years. The market growth is mainly driven by the increasing demand for Hydrazine Hydrate in various end-use industries, such as pharmaceuticals, agricultural chemicals, and polymerization reactions.

The pharmaceutical industry is one of the major end-users of Hydrazine Hydrate. It is used as a key intermediate in the production of various drugs, such as antitubercular drugs, antidepressants, and antineoplastic agents. The increasing prevalence of diseases and the growing demand for effective drugs are expected to drive the demand for Hydrazine Hydrate in the pharmaceutical industry.

The agricultural chemicals industry is another major end-user of Hydrazine Hydrate. It is used as a herbicide and pesticide in crop protection applications. The growing demand for food due to the increasing population is expected to drive the demand for Hydrazine Hydrate in the agricultural chemicals industry.

The polymerization reactions industry is also expected to drive the demand for Hydrazine Hydrate. It is used as a chain extender in the production of various polymers, such as polyurethane and polyester. The increasing demand for polymers in various end-use industries, such as automotive and construction, is expected to drive the demand for Hydrazine Hydrate.

[theacademicblog]

Humboldtia Vahl (Fabaceae): A review on ethnobotany, phytochemistry and pharmacology

Let's check out the new article!

A B S T R A C T Relevance: Humboldtia, a horticulturally potential, ecologically and medicinally valuable genus of subfamily Detarioideae has been reported with 7 species. The information on Ethnobotany, Phytochemistry and Pharmacology has been published with limited articles in reputed journals.Objectives: The main objective was to provide a cumulative information on taxonomy, ethnobotany,…

[ijcimr]

Calvarial Tuberculosis by Eleni Ischaki in International Journal of Clinical Images and Medical Reviews 

A 19-year-old boy presented with status epilepticus. Computed tomography of the brain showed a big, multilobular mass, with peripheral oedema in the frontal lobe which was enhanced peripherally after intravenous administration of a contrast agent. The mass penetrated the frontal bone and extended subcutaneously. He immediately underwent right decompression craniectomy. An empyema was found and was drained. Microscopic examination of brain, dura mater and bone tissue specimens revealed a necrotizing granulomatous inflammation. Tissue cultures were positive for Mycobacterium tuberculosis. The patient received a 4-regimen antitubercular treatment combined with dexamethasone due to central nervous system penetration of the disease with complete response in the follow-up.

For more details: https://ijcimr.org/editorial-board/ 

[medicomunicare]

TBC, the pandemic no one talks about in need for new solutions: unawareness or misleading?

TBC, the pandemic no one talks about in need for new solutions: unawareness or misleading?

Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis also called Bacillus of Koch, from the name of the scientist who discovered it in 1882. There are 5 varieties: human, bovine, avian, murine, cold-blooded animals; of these only the first 2 are of importance in human pathology. Worldwide, TB is the leading infectious cause of morbidity and mortality in adults, and…

[ptmasterguide]

Pyrazinamide

In this article, we will discuss Pyrazinamide (Overview). So, let’s get started. Pyrazinamide Clinical PharmacologyPyrazinamide is well absorbed from the GI tract and attains peak plasma concentrations within 2 hours. Plasma concentrations generally range from 30 to 50 mcg/mL with doses of 20 to 25 mg/kg. It is widely distributed in body tissues and fluids including the liver, lungs and…

[arshi19]

Antitubercular Drugs 1.2

Second Line Drugs

These are used when first line drugs when first line drugs cannot be used.

Kanamycin (Km), Amikacin (Am)

Similar to S.

Many S resistant strains and MDR strains of MDR strains of Mycobacterium tuberculosis remains sensitive.

The RNTCP standardized regimen for MDR-TB includes Km, but Am is preferred because of less toxicity.

Cross resistance is between Km and Am.

Both…

[youniverseisu]

Rifampicin uses :

antitubercular

leprosy

Streptococcal infection

brucellosis